Top Tweets for #DECAAF
Characterization of arrhythmia-induced cardiomyopathy using magnetic resonance imaging in patients with persistent #AFib and LVSD – insights from #DECAAF II
https://t.co/D4sxmNvZP4 #EJHF
@HanCardiomd @GiuseppeGalati_ @AmrAbdin10 @ESC_Journals
@DrJasonAndrade We observed similar outcomes from #DECAAF data. No difference in recurrence Ostial RF PVI vs WACA RF PVI vs Cryo @nmarrouche @Charbelnoujaim
#EUROPACE
Fresh off the press!
Catheter ablation improved ejection fraction in persistent #AF patients:
A #DECAAF-II sub analysis
@nmarrouche @EoinDonnellan1 @MekhaelMario
@DrJasonAndrade Agree
Symptoms are super messy but super important
AF burden is more straightforward - but we then need to define a minimum requirement for its measurement
Wouldnt daily plus symptom-based rhythm strips be enough (as in #DECAAF-II) ?
Or maybe semi-continuous wearable PPG ?
@jongichun @Leonard_Bergau @Phiso_de @BengelPhilipp @Helge_Haarmann Let’s check fibrosis from MRI and than we decide #DECAAF ReDo #MRI4All @nmarrouche @bisbal_EP @CMahnkopf @EPDeneke @Phiso_de @DrSEWilliams @Dominik_Linz
#SRuschitzka #ehra2022: the precious #LA! Careful ablating too much tissue! #myopathy #fibrosis #mri #EDORA #DECAAF @TulaneTriad
@chris_sohns #WAfib2022: Need for personalized approach to redo #Afib ablation. The rationale for #DECAAF-Redo @Phiso_de
@chris_sohns on the impact of #DECAAF 2 on #AFib treatment #PVI…
Great to see #DAS_CAM_2021 participants represented in the #FaFa2021 program!
🙏 @jongichun & @BorisSchmidt5
@ChristianHeeger @nmarrouche
@escardio @EHRAPresident @harry_crijns @RolandTilz
Die Erfolgsaussichten einer Pulmonalvenenisolation bei persistierenden #Vorhofflimmern sind beschränkt. Von der zusätzlichen Ablation atrialer Narbenareale erhofft man sich mehr Erfolg. #DECAAF hat die Hyptohese geprüft #ESCCongress https://t.co/VvV6cBCAlO
Congratulations @nmarrouche for conducting the #DECAAF II trial presented @ #ESCCongress.
👉No beneficial effect of imaging guided fibrosis ablation on AF recurrence
Follow the discussion: October 2nd
DGK Herztage 2021 https://t.co/UbPbwV3sN4 @AGEP_DGK @DGK_org #Epeeps @Phiso_de
#ESCCongress #AF #CardioTwitter #DECAAF II
No benefit of image guided fibrosis ablation in addition to PVI in patients with persistent AF
Infografias de los ensayos presentados en #ESCCongress
#MASTER-DAPT
#ENVISAGE-TAVI-AF
#APAF-CRT
#DECAAF-II
@DagherLilas @nmarrouche Great thread from @DagherLilas on #DECAAF-2 results. Huge congratulations to @nmarrouche and investigators for one of the largest randomized ablation trials! So much learned and many questions remain. Looking forward to digging into the data and publication!
More difficult to ablate scarred tissue - less #ablation depth vs normal tissue. Implications for #ablation, also #MRI guided (#DECAAF II)? Q: Design better metrics (EGM, impedance) to track lesion delivery? @nmarrouche @EladAnter @DrGregMichaud @suneet @GerdHindricks @drjohnm
Median depth in non-ischemic cardiomyopathy tissue was 7.2mm suggesting that greater depth is achieved in non-ischemic cardiomyopathy compared to in post-infarction tissue #AHAJournals #Epeeps https://t.co/vUhsE9Datc
#DECAAF II trial: 843 patients with persistent #AFib randomised to PVI plus imaging-guided fibrosis ablation or PVI alone
#ESCCongress
#DECAAF II trial: fibrosis #ablation shows promise in #AFib with low grade fibrotic myopathy
#ESCCongress
#DECAAF II trial: fibrosis #ablation shows promise in #AFib with low grade fibrotic myopathy
#ESCCongress
Enjoying the interesting presentation of #DECAAF-II trial finally.
The highlight of the #DAY2 of #ESCCongress
Many thanks to @nmarrouche for the great job and congratulations to the release today.
🕑 Look out for today’s #ESCCongress Late Breaking Clinical Trials at 14:00 CEST:
#MASTER_DAPT (4wk #DAPT after PCI)
#ENVISAGE (post #TAVI edoxaban vs. VKA in #AFib)
#FIGARO_DKD/Fidelity (finerenone)
#APAF_CRT (AV node ablation in AF)
#DECAAF II (MR-guided AF ablation)
👀
@nmarrouche on rhythm control in persistent #AFib
--> #AFib burden (wearables/ILRs) and atrial cardiomyopathy (imaging) -> new classification?
Important for rhythm outcome and stroke risk.
--> #DECAAF II trial will come.
#EHRA2021
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.4M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.1M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.4M followers
Virat Kohli
@imvkohli
70.5M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.4M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.1M followers
X
@x
60.8M followers